A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

First Patient Treated with Coronet Soft Tissue Fixation System

October 20, 2020

The first patient treated with Coronet Soft Tissue Fixation System was announced today by CoNextions Inc. Coronet Soft Tissue Fixation System in a Kidner procedure. The Kidner procedure is the most common surgical treatment for a painful accessory navicular bone that causes foot/tendon pain.

The Coronet Soft Tissue Fixation Systems is a tenodesis device intended for the fixation of soft tissue and tendon to bone.  During the Kidner procedure, a surgeon detaches the posterior tibial tendon from the bone and removes the pain-causing bone from the foot.  The posterior tibial tendon is then reattached to the navicular bone and secured with the Coronet.

Coronet’s novel design improves the soft tissue fixation strength of these repairs compared to conventional suture modalities.  A streamlined delivery system allows for the simultaneous placement of the implant in the bone and soft tissue and provides a knotless repair.  The Coronet is cleared for use by the FDA for the fixation of soft tissue to bone and tissue to tissue throughout numerous anatomical locations.  The first patient was treated by Youngstown, Ohio foot and ankle surgeon, Dr. Lawrence DiDomenico, at The Surgical Hospital at Southwoods.

“The Coronet was remarkably effective in streamlining the posterior tibial tendon reattachment portion of the Kidner procedure,” said Dr. DiDomenico.  “I am excited at the time efficiency the Coronet provided by not having to suture.  I also appreciate the ease of obtaining the appropriate tension with the Coronet versus suture.”

CoNextions Medical is currently launching the Coronet throughout the United States.  The device will be marketed by a network of orthopedic distributors across the country.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy